Obesity treatment: the key to managing the type 2 diabetes timebomb?

Abstract

Get full access to this article

View all access options for this article.

References

Medicare payment advisory commission. Healthcare Spending and the medicare program. 2004.

Currie CJ , Kraus D. , Morgan CL , Gill L. , Stott NCH , Peters JR NHS acute sector expenditure for diabetes: the present, future, and excess in-patient cost of care. Diabet Med 1997;14:686-92.

Chan JM , Stampfer MJ , Ribb EB , Willett WC , Colditz GA Obesity, fat distribution and weight gain as risk factors for clinical diabetes in man. Diabetes Care 1994;17:961-9.

Hu FB , Manson JE , Stampfer MJ et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001;345:790-7.

Jayapaul MK , Walker M. Mechanisms contributing to the development of type 2 diabetes. Br J Diabetes Vasc Dis 2004;4:227-31.

Pearson ER , Starkey BJ , Powell RJ , Gribble FM , Clark PM , Hattersley AT Genetic cause of hyperglycaemia and response to treatment in diabetes . Lancet 2003;362:1275-81.

Tuomilheto J. , Lindstrom J. , Erickson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle anongst subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.

Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.

Buchanan TA , Xiang AH , Peters RK et al. Protection from type 2 diabetes persists in the TRIPOD cohort eight months after stopping troglitazone. Diabetes 2001;50:A81.

10.

Chiasson JL , Josse RG , Gomis R. , Hanefeld M. , Karasik A. , Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial. Lancet 2002;359:2072-7.

11.

Torgerson JS , Hauptman J. , Boldrin MN , Sjostrom L. XENical in the prevention of diabetes in obese subjects (XENDOS) study. Diabetes Care 2004 ;27:155-61.

12.

Sjostrom CD , Lissner L. , Wedel H. , Sjostrom L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: The SOS Intervention Study. Obes Res 1999;7:477-84.

13.

Pories WJ , Swanson MS , MacDonald KG et al. Who would have thought it - an operation proves to be the most effective therapy for adult-onset diabetes-mellitus. Ann Surg 1995;222:339-52.

14.

Tringham JR , Davies MJ Screening for IGT and diabetes . Br J Diabetes Vasc Dis 2004;4:254-8.

15.

Banerjee M. , Cruickshank JK

`Prediabetes': is the term useful?

Br J Diabetes Vasc Dis 2004;4:221-5.

16.

Palmer AJ , Roze S. , Valentine WJ , Spinas GA , Shaw JE , Zimmet PZ Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: Modeling the long-term health economic implications of the Diabetes Prevention Program in Australia, France, Germany, Switzerland, and the United Kingdom. Clin Ther 2004;26:304-21.

17.

Mohanty P. , Aljada A. , Ghanim H. et al. Evidence for a potent antiinflammatory effect of rosiglitazone . J Clin Endocrinol Metab 2004;89:2728-35.

18.

Bennett SMA , Agrawal A. , Elashat H. et al. Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance. Diabet Med 2004;21:415-22.

19.

Sjostrom L. , Larsson B. , Backman L. , Bengtsson C. , Bouchard C. , Dahlgren S.e.a. Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes Relat Metab Disord 1992;16:465-79.

20.

Wing RR , Koeske R. , Epstein LH , Nowalk MP , Gooding W. , Becker D. Long-term effects of modest weight-loss in type-ii diabetic-patients . Arch Intern Med 1987;147:1749-53.

21.

McNulty SJ , Ur E. , Williams G. A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin. Diabetes Care 2003;26:125-31.

22.

Hollander PA , Elbein SC , Hirsch IB et al. Role of orlistat in the treatment of obese patients with type 2 diabetes - A 1-year randomized doubleblind study . Diabetes Care 1998;21:1288-94.

23.

Manley SE , Stratton IM , Cull CA et al. Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). UK Prospective Diabetes Study Group. Diabet Med 2000;17:518-23.

24.

Action for Health in Diabetes. http://www.nih.gov/news/pr/jun2001/niddk-25.htm

25.

Pinkney J. , Kerrigan D.

When should bariatric surgery be used in the treatment of type 2 diabetes?

Br J Diabetes Vasc Dis 2004;4:232-7.

26.

Sjostrom L. , Rissanen A. , Andersen T. et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients . Lancet 1998;352:167-72.

27.

James WPT , Astrup A. , Finer N. et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. Lancet 2000;356: 2119-25.

28.

UK Prospective Diabetes Study 7: response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients, UKPDS Group. Metabolism 1990;39:905-12.

29.

Dixon JB , O'Brien PE Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002;25:358-63.